Patents by Inventor Michael Anthony McKervey

Michael Anthony McKervey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7763596
    Abstract: This invention is directed to a method for treating an inflammatory condition, treating haematological and other malignancies, causing immunosuppression, or preventing or treating transplant rejection in man or other animals which comprises administering to a patient a compound that has the structure of Formula (I) or Formula (II) as defined below, or a pharmaceutically acceptable derivative thereof or pro-drug therefor, wherein R?NH2, NHR1, NHOR2, NHNHR2, NHCOR2, and R1?C(1-4)alkyl, C(3-6)cycloalkyl, Cn, where n=1-3, R2=methyl, ethyl, R3=alkyl, cycloalkyl, substituted alkyl, substituted cycloalkyl, aryl, heteroaryl, substituted aryl, or substituted hetrecoaryl; wherein R4, R5?C(1-4)alkyl. Novel compounds according to Formula (III), wherein R6 and R7 are any of H, CH3CO, CH3CH2CO, CH3CH2CH2CO provided that R6 and R7 are not both H, or Formula (IV), wherein R8 and R9 are any of H, CH3CO, CH3CH2CO or CH3CH2CH2CO, having use in such methods, are also described.
    Type: Grant
    Filed: April 19, 2007
    Date of Patent: July 27, 2010
    Assignee: The University of Manchester
    Inventors: Stephen Alexander Barr, Michael Anthony McKervey, Hughes Jean-Pierre Miel, David William Ray, Andrew Michael Brass
  • Patent number: 7067505
    Abstract: The present invention is a di-steroidal prodrug of estradiol having the following formula:
    Type: Grant
    Filed: December 10, 2004
    Date of Patent: June 27, 2006
    Assignee: Warner Chilcott Company, Inc.
    Inventors: John Alexander King, James Keown, James William McIlroy, William Paul Armstrong, Michael Anthony McKervey, Austin McMordie
  • Patent number: 7067504
    Abstract: The present invention is a di-steroidal prodrug of ethinyl estradiol according to formula I:
    Type: Grant
    Filed: December 10, 2004
    Date of Patent: June 27, 2006
    Assignee: Warner Chilcott Company, Inc.
    Inventors: John Alexander King, James Keown, James William McIlroy, William Paul Armstrong, Michael Anthony McKervey, Austin McMordie
  • Publication number: 20040102425
    Abstract: This invention is directed to a method for treating an inflammatory condition, treating haematological and other malignancies, causing immunosuppression, or preventing or treating transplant rejection in man or other animals which comprises administering to a patient a compound that has the structure of Formula (I) or Formula (II) as defined below, or a pharmaceutically acceptable derivative thereof or pro-drug therefor, wherein R=NH2, NHR1, NHOR2, NHNHR2, NHCOR2, and R1=C(1-4)alkyl, C(3-6)cycloalkyl, Cn, where n=1-3, R2=methyl, ethyl, R3=alkyl, cycloalkyl, substituted alkyl, substituted cycloalkyl, aryl, heteroaryl, substituted aryl, or substituted hetreoaryl; wherein R4, R5=C(1-4)alkyl. Novel compounds according to Formula (III), wherein R6 and R7 are any of H, CH3CO, CH3CH2CO, CH3CH2CH2CO provided that R6 and R7 are not both H, or Formula (IV), wherein R8 and R9 are any of H, CH3CO, CH3CH2CO or CH3CH2CH2CO, having use in such methods, are also described.
    Type: Application
    Filed: December 5, 2003
    Publication date: May 27, 2004
    Inventors: Alexander Stephen Barr, Michael Anthony McKervey, Hughes Jean-Pierre Miel, David William Ray, Andrew Michael Brass